Cal-Quick

Calpro is a Norwegian diagnostic company specializing in the development and commercialization of rapid tests for calprotectin, a key biomarker for intestinal inflammation. The company's flagship product, Cal-Quick (often marketed under the CalproSmart brand), is a rapid lateral flow test designed for the quantitative determination of calprotectin in stool samples. This technology allows patients with Inflammatory Bowel Disease (IBD), such as Crohn's disease and ulcerative colitis, to monitor their condition at home using a smartphone-based application. By providing real-time results, Calpro's solutions facilitate better disease management and reduce the need for invasive procedures like colonoscopies. The company serves a global market, providing tools for both clinical laboratories and point-of-care settings.